Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Change in Receivables (2018 - 2025)

Health Catalyst (HCAT) has disclosed Change in Receivables for 8 consecutive years, with -$7.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables fell 86.14% year-over-year to -$7.9 million, compared with a TTM value of $4.7 million through Sep 2025, down 37.88%, and an annual FY2024 reading of -$4.3 million, down 131.33% over the prior year.
  • Change in Receivables was -$7.9 million for Q3 2025 at Health Catalyst, down from $4.6 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $15.4 million in Q1 2023 and bottomed at -$9.5 million in Q2 2023.
  • Average Change in Receivables over 5 years is $589526.3, with a median of $919000.0 recorded in 2021.
  • The sharpest move saw Change in Receivables skyrocketed 2327.66% in 2022, then plummeted 395.85% in 2023.
  • Year by year, Change in Receivables stood at $919000.0 in 2021, then crashed by 272.8% to -$1.6 million in 2022, then surged by 976.7% to $13.9 million in 2023, then tumbled by 85.47% to $2.0 million in 2024, then plummeted by 491.7% to -$7.9 million in 2025.
  • Business Quant data shows Change in Receivables for HCAT at -$7.9 million in Q3 2025, $4.6 million in Q2 2025, and $6.1 million in Q1 2025.